BridgeBio Pharma, Inc.
看多

$BBIO * BRIDGEBIO PHARMA TC FIB EWP DAILY TF ANALYSIS

185
The chart is suggesting that BBIO is in the process of a Wave 4 correction, which should push the price lower in the short term. The correction appears to be reaching support levels near $18 or $17, which could be a good area for a reversal.

If the correction holds these levels, the next move could be a Wave 5 rally, targeting around $61 and above, based on previous wave structures and Fibonacci extensions.

The RSI is not yet in oversold territory, meaning there could still be some downside left in the current corrective wave before a reversal.

The technical analysis indicates a temporary pullback in BBIO stock, but with strong bullish potential in the medium term, aiming for new highs if the correction finds support around the $17-$18 level. The projected Wave 5 could bring significant upside momentum, potentially reaching up to $73.50

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。